Similar Articles
Neuroprotective Treatments in Parkinson’s Disease
Elif Çınar, Gul Yalçın Çakmaklı, Banu Cahide Tel
DOI: 10.4274/tnd.2019.01205
The Value of Autoantibody and Viral Serologic Examinations in the Differential Diagnosis of Multiple Sclerosis and Stroke
Ahmet Şair, Utku Ogan Akyıldız, Berna Korkmazgil, Nefati Kıylıoğlu
DOI: 10.4274/tnd.2019.09735
Predictors of Mortality in Patients with Surgically Treated Spontaneous Intracranial Hemorrhage
İsmail Kaya, İlker Deniz Cingöz, İnan Uzunoğlu, Ceren Kızmazoğlu, Hasan Emre Aydın, Nurullah Yüceer
DOI: 10.4274/tnd.2019.67365
Determination of Lipid Profile and Anthropometric Measurements of Multiple Sclerosis Patients: A Controlled Descriptive Study
Gülşen Delikanlı Akbay, Erdinç Karakullukçu, Aslı Akyol Mutlu, Halit Tanju Besler
DOI: 10.4274/tnd.2019.33341
The Prevalence of Alternative-complementary Therapies in Patients with Multiple Sclerosis
Rabia Gökçen Gözübatık Çelik, Musa Öztürk, Serap Altın, Mesrure Köseoğlu, Hande Sariahmetoğlu, Mesude Tütüncü, Aysun Soysal
DOI: 10.4274/tnd.2019.04207
What is the Effect of Accompanying Ankylosing Spondylitis in Treatment of Multiple Sclerosis? Is there a Resistance
Ezgi Akyıldız Tezcan, Hakan Ekmekçi, Gökhan Özdemir, Haluk Gümüş, Şerefnur Öztürk
DOI: 10.4274/tnd.2019.93206
Coexistence of Ankylosing Spondylitis and Multiple Sclerosis: Trigger with TNF-alpha Antagonist Therapy or Coincidental?
Bahar Say, Ufuk Ergün
DOI: 10.4274/tnd.2019.87513
Prognostic Value of Serum Neurofilaments in Patients with Clinically Isolated Syndromes
İpek Güngör Doğan
DOI: 10.4274/tnd.2019.97720
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results
Sami Ömerhoca, Sinem Yazıcı Akkaş, Zerrin Yıldırım Haşimoğlu, Sebatiye Erdoğan, Nilüfer Kale
DOI: 10.4274/tnd.2019.75725
Stenting of Carotid Artery Using the Brachial Artery Approach
Gökhan Özdemir, Gözde Ongun
DOI: 10.4274/tnd.2019.36604
Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
Halil Önder
DOI: 10.4274/tnd.2019.05925
Experience of Intravenous Thrombolytic Treatment in Sanliurfa: A Prospective Study
Murat Mert Atmaca, Özcan Kocatürk, Fidan Marufoğlu, Ahmet Candan Köylüoğlu, Melek Çolak Atmaca, Metin Balduz, Ayşenur Önalan, Emine Kargı
DOI: 10.4274/tnd.2018.69335
Analysis of Peripapillary Retinal Nerve Fiber Layer and Macular Volume in Patients with Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorders, and Healthy Controls Using Spectral Domain Optical Coherence Tomography in a Turkish Cohort
Ayşe İlksen Çolpak, Duygu Gülmez Sevim, Aslı Tuncer, Sevda Diker, Rana Karabudak, Sibel Kadayıfçılar, Tülay Kansu
DOI: 10.4274/tnd.2018.33230
Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
Miraç Ayşen Ünsal
DOI: 10.4274/tnd.2019.00187
Posterior Reversible Encephalopathy Syndrome in the Late Postpartum Period: A Case Report
Merve Melodi Çakar, Sezgin Kehaya, Hülya Özkan, Babürhan Feyzullah Güldiken
DOI: 10.4274/tnd.65481
A Treatable Reason of Myopathy: Hypothyroidism
Sibel Üstün Özek, Canan Emir, Selma Aygünoğlu, Cihat Örken
DOI: 10.4274/tnd.79999
Prognostic-disability Biomarkers in Multiple Sclerosis: Review of the Literature from the Last Five Years
Nefati Kıylıoğlu
DOI: 10.4274/tnd.79836
Posterior Auricular Muscle Response: Observations in Brainstem Lesions
Yeşim Gülen Abanoz, Yasin Abanoz, Yasemin Akıncı, Ayşegül Gündüz, Eser Buluş, Melih Tütüncü, Sabahattin Saip, Meral Erdemir Kızıltan
DOI: 10.4274/tnd.57255
Chronic Migraine: Burden, Comorbidities and Treatment
Aynur Özge, Derya Uludüz, Osman Özgür Yalın, Seden Demirci, Ömer Karadaş, Uğur Uygunoğlu, Aksel Siva
DOI: 10.4274/tnd.55563
Evaluation of Seizure After Stroke in Stroke Unit
Yasemin Dinç, Gülnur Tekgöl Uzuner, Büşra Emir
DOI: 10.4274/tnd.78545